Editorial

Published on 15 May 2024

Editorial: Substance use disorder: above and beyond addiction

in Neuropharmacology

Jaya Kumar
Wael Mohamed
Dasiel Oscar Borroto-Escuela
Muthuraju Sangu
Rusdi Rashid
Mohd Fadzli Mohamad Isa
Prem Kumar Shanmugam

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1426351

959 views

Original Research

Published on 10 May 2024

Comprehensive spectroscopic and computational insight into the binding of vanillin with human transferrin: targeting neuroinflammation in Alzheimer’s disease therapeutics

in Neuropharmacology

Mohammed Alrouji
Sabina Yasmin
Fahad A. Alhumaydhi
Sharaf E. Sharaf
Moyad Shahwan
Mohammad Furkan
Rizwan Hasan Khan
Anas Shamsi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1397332

1,322 views
2 citations

Review

Published on 06 May 2024

Teriparatide: an innovative and promising strategy for protecting the blood-spinal cord barrier following spinal cord injury

in Neuropharmacology

Moliang Xiong
Yun Feng
Caiguang Luo
Jia Guo
Jihuan Zeng
Liang Deng
Qiang Xiao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1386565

1,513 views
1 citation

Original Research

Published on 02 May 2024

Exosomes derived from HUVECs alleviate ischemia-reperfusion induced inflammation in neural cells by upregulating KLF14 expression

in Neuropharmacology

Jianxin Qin
Lihong Zhou
Lei Yu
Jingwen Ye
Feng Wang
Jin Zhou
Yunjuan Gu
Gang Chen
Xia Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1365928

1,536 views

Original Research

Published on 01 May 2024

Exploring the link between pyrethroids exposure and dopaminergic degeneration through morphometric, immunofluorescence, and in-silico approaches: the therapeutic role of chitosan-encapsulated curcumin nanoparticles

in Neuropharmacology

Badriyah S. Alotaibi
Amany Abdel-Rahman Mohamed
Yasmina M. Abd-Elhakim
Ahmed E. Noreldin
Moustafa Elhamouly
Tarek Khamis
Ali H. El-Far
Manal E. Alosaimi
Naief Dahran
Leena S. Alqahtani

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1388784

1,889 views
1 citation

Editorial

Published on 29 Apr 2024

Editorial: Exploring the key targets and compounds that manipulate brain neurocircuits against mental disorders and psychiatric

in Neuropharmacology

Weijie Xie
Song Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1411528

781 views

Original Research

Published on 29 Apr 2024

Erjingwan and Alzheimer’s disease: research based on network pharmacology and experimental confirmation

in Neuropharmacology

Yuya Xu
Jian Zhang
Xuling Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1328334

2,858 views

Original Research

Published on 26 Apr 2024

Exploring the potential use of melatonin as a modulator of tramadol-induced rewarding effects in rats

in Neuropharmacology

Alqassem Y. Hakami
Badrah S. Alghamdi
Fahad S. Alshehri

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1373746

1,629 views
1 citation

Review

Published on 25 Apr 2024

Psychostimulants and social behaviors

in Neuropharmacology

Valeska Cid-Jofré
Tamara Bahamondes
Agustina Zúñiga Correa
Ivalú Ahumada Arias
Miguel Reyes-Parada
Georgina M. Renard

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1364630

2,316 views

Original Research

Published on 25 Apr 2024

The effects of slow wave sleep characteristics on semantic, episodic, and procedural memory in people with epilepsy

in Neuropharmacology

Yvonne Höller
Stefanía Eyjólfsdóttir
Frank Jasper Van Schalkwijk
Eugen Trinka

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1374760

1,766 views
1 citation

Original Research

Published on 24 Apr 2024

Plasma IGFBP-3 and IGFBP-5 levels are decreased during acute manic episodes in bipolar disorder patients

in Neuropharmacology

Carlos Fernández-Pereira
Maria Aránzazu Penedo
Adrián Alonso-Núñez
Tania Rivera-Baltanás
Irene Viéitez
José María Prieto-González
María Isabel Vilariño-Vilariño
José Manuel Olivares
Saida Ortolano
Roberto Carlos Agís-Balboa

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1384198

2,152 views

Original Research

Published on 24 Apr 2024

Sporoderm-removed Ganoderma lucidum spores ameliorated early depression-like behavior in a rat model of sporadic Alzheimer’s disease

in Neuropharmacology

Yan Zhao
Yu Qin
Xiao Hu
Xi Chen
Yan-Ping Jiang
Xue-Jun Jin
Gao Li
Zhen-Hao Li
Ji-Hong Yang
Su-Ying Cui

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1406127

2,222 views
2 citations

Systematic Review

Published on 18 Apr 2024

Pathological mechanisms and future therapeutic directions of thrombin in intracerebral hemorrhage: a systematic review

in Neuropharmacology

Chenxi Tao
Yuanyuan Li
Na An
Haoqi Liu
Zhenhong Liu
Yikun Sun
Ying Qian
Na Li
Yanwei Xing
Yonghong Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1293428

1,490 views

Brief Research Report

Published on 18 Apr 2024

Effects of psilocybin, psychedelic mushroom extract and 5-hydroxytryptophan on brain immediate early gene expression: Interaction with serotonergic receptor modulators

in Neuropharmacology

Elad Lerer
Alexander Botvinnik
Orr Shahar
Meitar Grad
Karin Blakolmer
Noam Shomron
Amit Lotan
Bernard Lerer
Tzuri Lifschytz

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1391412

7,308 views
1 citation

Review

Published on 17 Apr 2024

Buty and the beast: the complex role of butyrate in Parkinson’s disease

in Neuropharmacology

Joshua D. Elford
Nanette Becht
Johan Garssen
Aletta D. Kraneveld
Paula Perez-Pardo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1388401

4,318 views
2 citations

Original Research

Published on 17 Apr 2024

Investigation of the shared biological mechanisms and common biomarker APTAF1 of sleep deprivation and mild cognitive impairment using integrated bioinformatics analysis

in Neuropharmacology

Xiaolan Liu
Baili Lu
Hui Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1387569

1,658 views

Navigation group

Articles

Editorial: Substance use disorder: above and beyond addiction

Comprehensive spectroscopic and computational insight into the binding of vanillin with human transferrin: targeting neuroinflammation in Alzheimer’s disease therapeutics

Teriparatide: an innovative and promising strategy for protecting the blood-spinal cord barrier following spinal cord injury

Exosomes derived from HUVECs alleviate ischemia-reperfusion induced inflammation in neural cells by upregulating KLF14 expression

Exploring the link between pyrethroids exposure and dopaminergic degeneration through morphometric, immunofluorescence, and in-silico approaches: the therapeutic role of chitosan-encapsulated curcumin nanoparticles

Editorial: Exploring the key targets and compounds that manipulate brain neurocircuits against mental disorders and psychiatric

Erjingwan and Alzheimer’s disease: research based on network pharmacology and experimental confirmation

Exploring the potential use of melatonin as a modulator of tramadol-induced rewarding effects in rats

Psychostimulants and social behaviors

The effects of slow wave sleep characteristics on semantic, episodic, and procedural memory in people with epilepsy

Plasma IGFBP-3 and IGFBP-5 levels are decreased during acute manic episodes in bipolar disorder patients

Sporoderm-removed Ganoderma lucidum spores ameliorated early depression-like behavior in a rat model of sporadic Alzheimer’s disease

Pathological mechanisms and future therapeutic directions of thrombin in intracerebral hemorrhage: a systematic review

Effects of psilocybin, psychedelic mushroom extract and 5-hydroxytryptophan on brain immediate early gene expression: Interaction with serotonergic receptor modulators

Buty and the beast: the complex role of butyrate in Parkinson’s disease

Investigation of the shared biological mechanisms and common biomarker APTAF1 of sleep deprivation and mild cognitive impairment using integrated bioinformatics analysis